Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review

被引:19
|
作者
Kim, Sang Jin [1 ,2 ]
Kim, Jong Man [3 ]
机构
[1] Korea Univ, Dept Surg, Coll Med, Seoul, South Korea
[2] Korea Univ, Div Hepatobiliopancreas & Transplant Surg, Ansan Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul, South Korea
关键词
Hepatocellular carcinoma; Liver transplantation; Recurrence; POSITRON-EMISSION-TOMOGRAPHY; ALPHA-FETOPROTEIN; TUMOR RECURRENCE; CLINICAL IMPACT; MILAN CRITERIA; PORTAL-VEIN; OUTCOMES; CANCER; RISK; HCC;
D O I
10.3350/cmh.2022.0060
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver transplantation (LT) is one of the most effective treatments for hepatocellular carcinoma (HCC). Although LT eliminates HCC and greatly reduces recurrence, some patients experience recurrence after LT. Criteria and models for screening patients with a high probability of HCC recurrence after LT, starting with the Milan criteria, have been published. These models have changed over time, but a standard has not been established. We summarized HCC prediction models after LT by focusing on the application of radiologic, serologic, and pathologic factors and recent trends. This review will look at studies that are based on living donor LT and deceased donor LT, as well as studies that downstaging procedures have been performed preoperatively. This ultimately aims to help make decisions for evaluating the HCC state and selecting candidates for LT according to the circumstances of each transplantation center.
引用
收藏
页码:739 / 753
页数:15
相关论文
共 50 条
  • [31] Liver Transplantation for Pediatric Hepatocellular Carcinoma: A Systematic Review
    Kakos, Christos D.
    Ziogas, Ioannis A.
    Demiri, Charikleia D.
    Esagian, Stepan M.
    Economopoulos, Konstantinos P.
    Moris, Dimitrios
    Tsoulfas, Georgios
    Alexopoulos, Sophoclis P.
    CANCERS, 2022, 14 (05)
  • [32] Hepatocellular Carcinoma and the Role of Liver Transplantation: An Update and Review
    Sequeira, Lynette M.
    Ozturk, N. Begum
    Sierra, Leandro
    Gurakar, Merve
    Toruner, Merih Deniz
    Zheng, Melanie
    Simsek, Cem
    Gurakar, Ahmet
    Kim, Amy K.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2025, : 327 - 338
  • [33] Molecular Clues for Prediction of Hepatocellular Carcinoma Recurrence After Liver Transplantation
    Badwei, Nourhan
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (05) : 804 - 812
  • [34] Glutamate Dehydrogenase and Alkaline Phosphatase as Very Early Predictors of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    Piras-Straub, Katja
    Khairzada, Khaleda
    Gerken, Guido
    Saner, Fuat
    Treckmann, Juergen
    Paul, Andreas
    Canbay, Ali
    Herzer, Kerstin
    DIGESTION, 2015, 91 (02) : 117 - 127
  • [35] Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
    Qu, Wei-Feng
    Tian, Meng-Xin
    Lu, Hong-Wei
    Zhou, Yu-Fu
    Liu, Wei-Ren
    Tang, Zheng
    Yao, Zhao
    Huang, Run
    Zhu, Gui-Qi
    Jiang, Xi-Fei
    Tao, Chen-Yang
    Fang, Yuan
    Gao, Jun
    Wu, Xiao-Ling
    Chen, Jia-Feng
    Zhao, Qian-Fu
    Yang, Rui
    Chu, Tian-Hao
    Zhou, Jian
    Fan, Jia
    Yu, Jin-Hua
    Shi, Ying-Hong
    HEPATOLOGY INTERNATIONAL, 2023, 17 (04) : 927 - 941
  • [36] Early recurrence of hepatocellular carcinoma after living donor liver transplantation
    Ohkubo, T
    Sugawara, Y
    Imamura, H
    Kaneko, J
    Matsui, Y
    Makuuchi, M
    HEPATO-GASTROENTEROLOGY, 2004, 51 (55) : 237 - 238
  • [37] No impact of donor sex on the recurrence of hepatocellular carcinoma after liver transplantation
    Taura, Kojiro
    Shimamura, Tsuyoshi
    Akamatsu, Nobuhisa
    Umeshita, Koji
    Fujiyoshi, Masato
    Abe, Hiroyasu
    Morita, Satoshi
    Uemoto, Shinji
    Eguchi, Susumu
    Furukawa, Hiroyuki
    Takada, Yasutsugu
    Egawa, Hiroto
    Ohdan, Hideki
    Hatano, Etsuro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2022, 29 (05) : 570 - 584
  • [38] Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma
    Shah, Shimul A.
    Tan, Jensen C. C.
    McGilvray, Ian D.
    Cattral, Mark S.
    Cleary, Sean P.
    Levy, Gary A.
    Greig, Paul D.
    Grant, David R.
    TRANSPLANTATION, 2006, 81 (12) : 1633 - 1639
  • [39] The Value of Serum α-Fetoprotein in Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
    Xu, Xiao
    Ke, Qing-Hong
    Shao, Zhe-Xin
    Wu, Jian
    Chen, Jun
    Zhou, Lin
    Zheng, Shu-Sen
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (02) : 385 - 388
  • [40] Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation
    Norma Arteiro Filgueira
    World Journal of Hepatology, 2019, (03) : 261 - 272